The present invention relates to the use of silver(l) monophosphine complexes as Active Pharmaceutical Ingredients (API s) including anticancer agents for the treatment diagnosis and/or prevention of cancer. The present invention also relates to pharmaceutical compositions containing such complexes and further extends to a method of treating or diagnosing a subject/patient suffering from cancer.
